B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GALNT10

MOLECULAR TARGET

polypeptide N-acetylgalactosaminyltransferase 10

UniProt: Q86SR1NCBI Gene: 555681 compounds

GALNT10 (polypeptide N-acetylgalactosaminyltransferase 10) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GALNT10

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1urolithin d0.691

About GALNT10 as a Drug Target

GALNT10 (polypeptide N-acetylgalactosaminyltransferase 10) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented GALNT10 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GALNT10 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.